t.wojcik

TL2 · Galway

Contributes reviews on supplier material. Based in Galway.

Joined 23 October 2024 · last posted 11d

79 posts, newest first. Showing up to 150.

Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #46 · Documentation › Doc review · 17 Jul 2026 · 0 likes A review date is a commitment rather than a formality, and a shorter cycle for a fast-moving subject is the whole point of setting it deliberately. Not a strong…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #101 · Sourcing › Vendor reports · 13 Jul 2026 · 3 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
A single out-of-range value on an otherwise normal panel Replied, post #69 · Clinical › Bloodwork · 6 Jul 2026 · 2 likes Picking up post #66: that is the part I would want checked first. The number people quote for single out-of-range value is a central estimate presented without its…
How much context is too much context in a first post? Replied, post #28 · Start Here › How to Ask · 6 Jul 2026 · 4 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
About the Shortages category Replied, post #5 · Access › Shortages · 2 Jul 2026 · 13 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
Journal club: what we got wrong in an earlier session Replied, post #39 · Evidence › Journal club · 29 Jun 2026 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. Worth starting from what the authors set out to estimate rather than what they…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #80 · Compounds › Repair & healing peptides · 27 Jun 2026 · 10 likes The reason Stability of BPC-157 keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Coming back to: Time to steady state after a dose increase Replied, post #83 · Pharmacology › Pharmacokinetics · 22 Jun 2026 · 28 likes Everything in post #79 holds. The case it does not cover is the one I have. The time to maximum concentration after a subcutaneous dose in this class is measured in…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #95 · Practice › Side effects · 18 Jun 2026 · 24 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #59 · Safety › Contraindications · 2 Jun 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
Comparing prices across jurisdictions without misleading yourself Replied, post #15 · Access › Pricing · 29 May 2026 · 0 likes Adding the measurement that post #12 says would settle it. List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #33 · Compounds › Semaglutide · 20 May 2026 · 28 likes Right — I had this wrong and I am glad to have read it before it mattered.
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #114 · Devices › Syringes & needles · 13 May 2026 · 11 likes Coming back to post #113, because the follow-up matters more than the original answer. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels…
Coming back to: A structured critique template this community uses Replied, post #9 · Evidence › Study critique · 10 May 2026 · 0 likes Post #8 is right about the mechanism and I think understates the practical bit. A critique should end with what would change your mind. Without that it is a position…
Revisiting: What pooling buys you and what it destroys Replied, post #16 · Evidence › Meta-analyses · 8 May 2026 · 3 likes An update on my earlier pooling buys post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Fasting versus non-fasting and which tests care Replied, post #23 · Clinical › Bloodwork · 5 May 2026 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #12 · Compounds › Retatrutide · 4 May 2026 · 2 likes Coming back to post #10, because the follow-up matters more than the original answer. Whether triple agonism is additive or synergistic is an open question and the…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #33 · Evidence › Journal club · 7 Apr 2026 · 0 likes On post #29 — agreed on the reasoning, with one qualification. Posting my SURMOUNT-1 numbers with the method attached so they can be discounted properly. Uncontrolled,…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #27 · Meta › Announcements · 7 Apr 2026 · 14 likes Trust level 3 requirements: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #44 · Compounds › Semaglutide · 27 Mar 2026 · 32 likes Nausea is dose-related and adaptation-related, and both are true at once. The pattern most people describe is a return of symptoms at each escalation followed by…
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 2 Mar 2026 · 13 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
Coming back to: Reading a supplier's product description as a marketing document Replied, post #34 · Compounds › Other compounds · 23 Feb 2026 · 3 likes The tanning compounds carry a specific practical point that is not pharmacological: any change to a pigmented lesion is a reason to see a clinician, and that is not a…
[2026 update] Long-time reader, first-time poster Replied, post #44 · Lounge › Introductions · 23 Jan 2026 · 29 likes A note on how Long-time reader gets discussed rather than on Long-time reader itself: the confident posts get the replies and the careful ones get ignored, and the…
Storing lyophilised material long term: what governs the shelf life Replied, post #32 · Practice › Storage & stability · 20 Jan 2026 · 10 likes Taking post #29 at face value and following it one step further. The two questions that get merged here are whether material is degraded and whether it is contaminated.…
What "verified" means on our vendor pages, stated narrowly Replied, post #7 · Sourcing › Vendor reports · 24 Dec 2025 · 13 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if…
Micro-titration: a disputed topic, argued properly Replied, post #13 · Practice › Dosing & titration · 18 Dec 2025 · 0 likes Confirming post #10 from a second method, which matters more than confirming it from a second person. The strongest argument against my own position on micro-titration,…
Stepping down deliberately, and how to do it without losing progress Replied, post #25 · Practice › Dosing & titration · 9 Dec 2025 · 16 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #17 · Practice › Interactions · 7 Dec 2025 · 27 likes Answering the question post #14 raises rather than the one it answers. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
DXA precision and the least significant change for lean mass Replied, post #36 · Outcomes › Body composition · 2 Dec 2025 · 12 likes Building on post #35 rather than restating it. Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for…
Tracking that stops updating and then resumes — the long version Replied, post #36 · Sourcing › Logistics · 9 Nov 2025 · 1 like Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
Coming back to: Why quantitation is the hard part, not detection Replied, post #91 · Analytics › Home & field testing · 9 Nov 2025 · 0 likes Post #89 and I disagree about the size of the effect, not about the direction. A home refractometer is not measuring what people hope it is measuring in these…
EMA product information as a primary source Replied, post #21 · Regional › European Union · 1 Nov 2025 · 3 likes Post #18 is right about the mechanism and I think understates the practical bit. Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance…
Appeal templates and why they are deliberately unemotional Replied, post #20 · Access › Insurance & coverage · 26 Oct 2025 · 0 likes Appeal templates: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #52 · Start Here › Welcome · 17 Oct 2025 · 10 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Liver enzymes drifting down and what that usually means Replied, post #13 · Clinical › Bloodwork · 22 Sep 2025 · 3 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #57 · Evidence › Study critique · 14 Sep 2025 · 21 likes Building on post #54 rather than restating it. I have three months of notes on Reverse causation and the honest summary is that the trend is real and the week-to-week…
Journal club: STEP-HFpEF and symptom endpoints Replied, post #4 · Evidence › Journal club · 31 Aug 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
Revisiting: Filter needles: when they help and what they cost you Replied, post #48 · Devices › Syringes & needles · 22 Aug 2025 · 4 likes Building on post #45 rather than restating it. On Filter needles the community has more anecdote than the confidence in this thread implies, and I include my own…
Which panel is worth repeating and which is worth ignoring Replied, post #77 · Clinical › Bloodwork · 5 Aug 2025 · 0 likes Adding the measurement that post #74 says would settle it. Two claims get bundled together under panel and they need separating. The descriptive one — this is what was…
Travel coolers and how long they really hold Replied, post #19 · Devices › Cold chain · 1 Aug 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
Checking someone else's arithmetic: a worked example thread Replied, post #72 · Practice › Reconstitution · 29 Jul 2025 · 17 likes On post #70 — agreed on the reasoning, with one qualification. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #30 · Sourcing › Vendor reports · 25 Jul 2025 · 25 likes Nothing to add, except that this is the answer I would give if asked.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #53 · Access › Insurance & coverage · 22 Jul 2025 · 14 likes Checked the Reading a denial letter claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower…
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #11 · Practice › Dosing & titration · 12 Jul 2025 · 12 likes Coming back to post #7, because the follow-up matters more than the original answer. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #137 · Devices › Cold chain · 6 Jul 2025 · 2 likes Coming back to post #133, because the follow-up matters more than the original answer. Temperature excursions: brief excursions above 8 °C are tolerable for most…
[2026 update] Constipation management, with a dietitian's contribution Replied, post #5 · Practice › Side effects · 16 Jun 2025 · 20 likes I would call the community position on Constipation management likely rather than established, and I would be comfortable defending that hedge.
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #69 · Practice › Reconstitution · 13 Jun 2025 · 1 like The practical version of 10 mg vial reconstituted three is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
A report I filed that turned out to be wrong, and the correction Replied, post #101 · Sourcing › Vendor reports · 13 Jun 2025 · 10 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. The uncertainty is in…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #39 · Evidence › Trials · 12 Jun 2025 · 0 likes I would put moderate confidence on the mainstream reading of Sample size calculations and no more. That is not scepticism for its own sake; it is where the sourcing…
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #12 · Analytics › Method validation · 9 Jun 2025 · 4 likes Worth separating two things that post #10 runs together. Specificity: the method can distinguish the intended compound from related impurities and degradation products.…
Pre-registering a personal experiment, seriously Replied, post #15 · Research Methods › N-of-1 designs · 26 May 2025 · 17 likes Measure the same thing the same way at the same time of day. Most of the noise in personal data is measurement protocol rather than biology. Anyone who has looked at…
Why oral semaglutide needs an absorption enhancer at all Replied, post #6 · Compounds › Oral incretins · 14 May 2025 · 0 likes Building on post #5 rather than restating it. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the…
Coming back to: Official shortage notices and what they authorise Replied, post #4 · Access › Shortages · 10 May 2025 · 6 likes The opening post is right about the mechanism and I think understates the practical bit. Managing an unplanned gap: if a shortage causes a gap in treatment, the…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Started this topic · Compounds › Oral incretins · 4 May 2025 · 42 likes The SOUL trial and oral semaglutide cardiovascular outcomes — setting out what I have, and where I think it stops being reliable. SOUL trial and oral semaglutide — I…
Reading an MS report that only gives you a single number Replied, post #65 · Analytics › Mass spectrometry · 29 Apr 2025 · 22 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
Retatrutide dose escalation in the published trials Replied, post #155 · Compounds › Retatrutide · 19 Apr 2025 · 2 likes Retatrutide dose escalation has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #5 · Practice › Reconstitution · 18 Apr 2025 · 20 likes Everything in the opening post holds. The case it does not cover is the one I have. Choosing a concentration on purpose rather than by accident: starting with "I want…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #21 · Compounds › Retatrutide · 14 Apr 2025 · 14 likes Where I would push back on the Retatrutide mass and identity consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #11 · Devices › Pens & autoinjectors · 3 Apr 2025 · 8 likes Injection duration: most pens deliver the dose over several seconds. Holding the button down for the full duration ensures complete delivery. Releasing early can result…
Counter-ion form: the field almost nobody reports — one year on Replied, post #11 · Analytics › COA interpretation · 19 Feb 2025 · 5 likes Summarising the Counter-ion form thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
Cost per milligram, computed honestly across formats — the long version Replied, post #10 · Access › Pricing · 15 Feb 2025 · 10 likes This follows post #9 rather than contradicting it. A cheaper option that arrives slowly has a cost in the form of running out, and people rarely price that.
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #44 · Clinical › Bloodwork · 4 Feb 2025 · 1 like Adding a note of thanks rather than an opinion. I did not know most of that.
Second pass at: Regression to the mean in progress reports Replied, post #34 · Research Methods › Statistics · 24 Jan 2025 · 0 likes Coming back to post #30, because the follow-up matters more than the original answer. Regression is a good example of a question where the honest answer is boring and…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #3 · Clinical › Comorbidities · 24 Jan 2025 · 0 likes Narrowing the opening post, because the general version has more than one answer. Whatever the answer on obstructive sleep apnoea turns out to be, the method for…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #20 · Pharmacology › Receptor biology · 7 Jan 2025 · 10 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #10 · Compounds › Secretagogues & GH axis · 31 Dec 2024 · 1 like No notes. Posting so the count is not one.
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #113 · Compounds › Tirzepatide · 27 Dec 2024 · 6 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
Triple agonism: additive, synergistic, or neither? Replied, post #4 · Compounds › Retatrutide · 16 Dec 2024 · 0 likes Marking my uncertainty on triple agonism explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
Promotion criteria, and the one that stops most nominations Replied, post #112 · Documentation › Doc review · 13 Nov 2024 · 15 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. Old habit: I write down the expected answer…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #23 · Compounds › Repair & healing peptides · 9 Nov 2024 · 0 likes The absence of human trials means there is no established dose, no established interval and no established duration. Protocols circulating in this space are convention…
Irish differences from the UK position Replied, post #65 · Regional › UK & Ireland · 29 Oct 2024 · 0 likes Picking up post #62: that is the part I would want checked first. Checked the irish differences claim against the primary source this morning. It survives, with a…
Research-use-only status: what it means legally and practically — a second dataset Started this topic · Compounds › Other compounds · 6 Oct 2024 · 26 likes Research-use-only status: what it means legally and practically — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #83 · Clinical › Bloodwork · 5 Oct 2024 · 7 likes Where I part company with post #81, and it is a narrow parting. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #128 · Nutrition & Training › Hydration & electrolytes · 2 Oct 2024 · 3 likes Commercial rehydration formulations are designed for a specific purpose and are not equivalent to a sports drink, whatever the marketing suggests.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #73 · Practice › Dosing & titration · 29 Sep 2024 · 27 likes Building on post #72 rather than restating it. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others…
SURPASS-2 and the comparator dose question that will not go away Replied, post #24 · Compounds › Tirzepatide · 29 Sep 2024 · 5 likes SURPASS-2's comparator choice is the criticism that survives. Semaglutide 1.0 mg was the licensed diabetes dose at the time and it was not the highest dose available in…
Converting between mg/mL and units per dose, both directions Replied, post #33 · Practice › Reconstitution · 28 Sep 2024 · 0 likes Answering the question post #31 raises rather than the one it answers. Preservative effectiveness is tested against a defined microbial challenge under defined…
Second pass at: Journal club: LEADER as the historical anchor Replied, post #21 · Evidence › Journal club · 12 Jul 2024 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping. I…
Oral contraceptives and delayed emptying: what the data shows Replied, post #25 · Practice › Interactions · 10 Jul 2024 · 9 likes Post #22 is the version of this I will quote in future. One addition. Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already…